
New Kerecis Medical-Fish-Skin Product Gets Quick Approval from Medicare Administrative Contractors
More than 40% of the Medicare population now enjoys coverage for Kerecis Shield. Multiple Medicare
More than 40% of the Medicare population now enjoys coverage for Kerecis Shield. Multiple Medicare
Arlington, VA and Reykjavik, Iceland—August 14, 2023—Kerecis®, the company pioneering the use of fish-skin and
Today Coloplast announced the following statement. We’re excited to join the Coloplast family and have
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy.
© 2010-2023 Kerecis. All Rights Reserved